Fascial Tissue Response to Manual Therapy: Implications in Long COVID-19

NCT06348186 | Recruiting

• 1 other identifier: Fascial Tissue Response
• Study Type: interventional
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

According to the World Health Organization (WHO), as of mid-September 2022, more than 21 million Brazilians have recovered from COVID-19. However, post-infection symptoms continue to appear months after the end of the acute infection, a syndrome called long COVID. Therefore, the aim of this study is to investigate the responses of fascia-focused manual therapy in participants with long COVID.

Conditions

COVID-19

Keywords

Long COVID; Manual Therapy; Fascia; Rehabilitation

Outcome Measures

Primary Outcomes (2)

• Functioning and disability

  Will be assessed using the "World Health Organization Disability Assessment" questionnaire (WHO-DAS 2.0), translated and validated for the Brazilian population by Silveira et al. (2013).

  6 weeks

• Biomechanical and tissue viscoelastic properties

  Will be evaluated by MyotonPro (MytonPro, Myoton Ltd.s., Tartu, Estonia)

  6 weeks

Secondary Outcomes (4)

• Work capacity

  6 weeks

• Level of Quality of life

  6 weeks

• Upper limb dysfunctions

  6 weeks

• Balance

  6 weeks

Study Arms (2)

Guidebook

OTHER

Other: Guidebook

Guidebook and Myofascial Reorganization® (RMF).

EXPERIMENTAL

Other: Guidebook and Myofascial Reorganization® (RMF).

Interventions

Guidebook OTHER

Folder that will be given to the participant to carry out 5 minutes of intervention daily

Guidebook

Guidebook and Myofascial Reorganization® (RMF). OTHER

The intervention will be carried out once a week for 30 minutes for 6 weeks. It will include passive, active-assisted moments (with and without load). In addition to a folder that will be given to the participant to carry out 5 minutes of intervention daily.

Guidebook and Myofascial Reorganization® (RMF).

Eligibility Criteria

• Age: 20 Years - 80 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Participants diagnosed with long COVID, of both sexes, aged between 20 and 80 years, from the community, outpatient clinics and hospitals.

You may not qualify if:

• Participants with suspected deep vein thrombosis; Participants with neurological disorders.

Sponsors & Collaborators

• University of the State of Santa Catarina: lead
• Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina: collaborator

Study Sites (1)

Santa Catarina State University

Florianópolis, Santa Catarina, 88.035-001, Brazil

RECRUITING

MeSH Terms

Conditions

COVID-19; Post-Acute COVID-19 Syndrome

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases; Post-Infectious Disorders; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Central Study Contacts

Larissa Sinhorim

CONTACT

47984057340; larissasinhorim@hotmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Professor

Model Details: Participants are randomly assigned to one of two or groups, typically an intervention group (fascia-focused manual therapy) and a control group. Participants are randomly allocated. Participants and outcomes assessor are blinded.

Study Record Dates

• First Submitted: April 3, 2024
• First Posted: April 4, 2024
• Study Start: February 1, 2024
• Primary Completion: April 1, 2024
• Study Completion: August 31, 2025
• Last Updated: November 20, 2024

Record last verified: 2024-05

Data Sharing

• IPD Sharing: Will not share

Locations

BR (1)